Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 3;10(3):e0118492.
doi: 10.1371/journal.pone.0118492. eCollection 2015.

Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France

Collaborators, Affiliations

Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France

Laure-Amélie de Monteynard et al. PLoS One. .

Abstract

Objective: To compare the time from entry into care for HIV infection until combination antiretroviral therapy (cART) initiation between migrants and non migrants in France, excluding late access to care.

Methods: Antiretroviral-naïve HIV-1-infected individuals newly enrolled in the FHDH cohort between 2002-2010, with CD4 cell counts >200/μL and no previous or current AIDS events were included. In three baseline CD4 cell count strata (200-349, 350-499, ≥ 500/μL), we examined the crude time until cART initiation within three years after enrollment according to geographic origin, and multivariable hazard ratios according to geographic origin, gender and HIV-transmission group, with adjustment for baseline age, enrollment period, region of care, plasma viral load, and HBV/HBC coinfection.

Results: Among 13338 individuals, 9605 (72.1%) were French natives (FRA), 2873 (21.4%) were migrants from sub-Saharan Africa/non-French West Indies (SSA/NFW), and 860 (6.5%) were migrants from other countries. Kaplan-Meier probabilities of cART initiation were significantly lower in SSA/NFW than in FRA individuals throughout the study period, regardless of the baseline CD4 stratum. After adjustment, the likelihood of cART initiation was respectively 15% (95%CI, 1-28) and 20% (95%CI, 2-38) lower in SSA/NFW men than in FRA men who had sex with men (MSM) in the 350-499 and ≥ 500 CD4 strata, while no difference was observed between other migrant groups and FRA MSM.

Conclusion: SSA/NFW migrant men living in France with CD4 >350/μL at entry into care are more likely to begin cART later than FRA MSM, despite free access to treatment. Administrative delays in obtaining healthcare coverage do not appear to be responsible.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Individuals selection.
Abbreviations: ADE, AIDS-defining event; cART, combination antiretroviral therapy; NRTI, Nucleoside Reverse Transcriptase Inhibitor.
Fig 2
Fig 2. Kaplan-Meier survival estimates of first-line cART initiation by geographic origin and CD4 cell counts [/μL] at enrolment.
Abbreviations: cART, combination antiretroviral therapy; FRA, French natives; SSA, sub-Saharan Africa; NFW, non-French West Indies; OTH, Other regions of the world.
Fig 3
Fig 3. Univariate and multivariate Hazard Ratios (HRs) for cART initiation according to geographic origin, gender and HIV transmission group in baseline CD4 cell count strata (Cox model).
* HR adjusted for age at enrolment, enrolment period, region of care, pVL at enrolment, and hepatitis B antigen and hepatitis C antibody status; Abbreviations: cART, Combination antiretroviral therapy; FRA, French natives; SSA, sub-Saharan Africa; NFW, non-French West Indies; OTH, Other regions of the world; MSM, Men who have sex with men.

References

    1. Bouvier G. Les descendants d’immigrés plus nombreux que les immigrés: une position originale en Europe. INSEE 2010. Available: http://www.insee.fr/fr/ffc/docs_ffc/ref/IMMFRA12_b_VE_posfra.pdf Accessed 2014 Apr 7.
    1. Cazein F, Lot F, Pillonel J, Le Strat Y, Sommen C, Pinget R et al. New HIV and AIDS diagnoses—France, 2003–2012. Bull Epidémiol Hebd 2014; 154–62. Available: http://www.invs.sante.fr/beh/2014/9-10/2014_9-10_1.html Accessed 2014 Apr 7.
    1. Lot F, Pillonel J, Pinget R, Cazein F, Bernillon P, Leclerc M, et al. AIDS indicative diseases, France, 2003–2010. Bull Epidémiol Hebd 2011; 454–458. Available: http://opac.invs.sante.fr/doc_num.php?explnum_id=7643 Accessed 2014 Apr 7.
    1. Monge S, Alejos B, Dronda F, Del Romero J, Iribarren J, Pulido F, et al. Inequalities in HIV disease management and progession in migrants from Latin America and sub-Saharan Africa living in Spain. HIV med 2012; 273–83. - PubMed
    1. Mocroft A, Lundgren JD, Sabin ML, Monforte A d’Arminio, Brockmeyer N, Casabona J, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the collaboration of observational HIV epidemiological research Europe study (COHERE). PloS Med 2013; 10:e1001510 10.1371/journal.pmed.1001510 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances